![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() by Brooks Hays Washington (UPI) Feb 27, 2018
Scientists know what makes magic mushrooms magical, a chemical compound called psilocybin. But researchers have been less clear on how and why mushrooms evolve to produce the psychedelic ingredient. New research offers clues. What's so unusual about magic mushrooms is that the species that produce psilocybin aren't closely related. They trace their roots to divergent lineages and boast unique genomes. To better understand the relationship between different magic mushrooms, scientists sequenced the genomes of three psychedelic mushrooms species and compared them to the genomes of several of their non-psychedelic relatives. The comparative analysis revealed a group of genes shared by the three magic mushrooms. Still, the analysis didn't answer the scientists' chief question: how and why did psilocybin evolve? In a search for more answers, scientists looked to the origin of the species' shared genes. Researchers believe the magic mushrooms share the genetic code for psilocybin production through a process called horizontal gene transfer. Scientists hypothesized that magic mushrooms shared these genes in an environment rich with fungus-eating insects -- an environment such as animal manure and rotting wood. Psilocybin's brain-altering abilities don't just impact humans, they also disrupt the normal neural processes of insects. Research has shown that the compound depresses the appetite of flies. "We speculate that mushrooms evolved to be hallucinogenic because it lowered the chances of the fungi getting eaten by insects," Jason Slot, an assistant professor of fungal evolutionary genomics at Ohio State University, said in a news release. Slot and his colleague published their hypothesis in the journal Evolution Letters. "The psilocybin probably doesn't just poison predators or taste bad," Slot said. "These mushrooms are altering the insects' 'mind' -- if they have minds -- to meet their own needs." Several studies have looked at the potential of psilocybin as treatment for mental health problems like anxiety and depression. Slot and his research partners suggest their work can help scientists better understand theses brain-altering molecules.
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |